Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Prostatic Neoplasms 3Neoplasms 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hemangioma 2Carcinoma, Non-Small-Cell Lung 2Radiation Pneumonitis 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases, Interstitial 1Leukemia, Hairy Cell 1Leukemia 1Hepatitis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Chemical and Drug Induced Liver Injury 1Bulbo-Spinal Atrophy, X-Linked 1Brain Neoplasms 1

Interventions

Timolol 3Propranolol 3Solutions 2Prednisone 2Prednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Saline Solution 1Ointments 1Mupirocin 1Methylprednisolone 1Imiquimod 1Gels 1Everolimus 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Hemangioma × Adrenal Cortex Hormones × Clear all
NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT01072045 2014-12-02

Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma

University of Sao Paulo

Phase 2 Completed
50 enrolled

Hemangioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡